GENiusVac, a novel immunotherapeutic strategy based on a potent plasmacytoid dendritic cell (pDC) line

被引:0
|
作者
Aspord, Caroline
Julie, Charles
Marie-Therese, Leccia
Jean-Paul, Molens
Laurence, Chaperot
Joel, Plumas
机构
[1] Inserm 823, Paris, France
[2] CHU Grenoble, Grenoble, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
25
引用
收藏
页码:S22 / S23
页数:2
相关论文
共 50 条
  • [31] Activation of the Leukemia Plasmacytoid Dendritic Cell Line PMDC05 by Toho-1, a Novel IDO Inhibitor
    Yamahira, Akie
    Narita, Miwako
    Iwabuchi, Minami
    Uchiyama, Takayoshi
    Iwaya, Shunpei
    Ohiwa, Rie
    Nishizawa, Yoshinori
    Suzuki, Takafumi
    Yokoyama, Yusaku
    Hashimoto, Shigeo
    Takizawa, Jun
    Sone, Hirohito
    Takahashi, Masuhiro
    ANTICANCER RESEARCH, 2014, 34 (08) : 4021 - 4028
  • [32] Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis
    Togami, Katsuhiro
    Chung, Sun Sook
    Madan, Vikas
    Kenyon, Christopher M.
    Cabal-Hierro, Lucia
    Taylor, Justin
    Kim, Sunhee
    Griffin, Gabriel K.
    Ghandi, Mahmoud
    Li, Jia
    Li, Yvonne Y.
    Angelot-Delletre, Fanny
    Biichle, Sabeha
    Seiler, Michael
    Buonamici, Silvia
    Lovitch, Scott B.
    Louissaint, Abner, Jr.
    Morgan, Elizabeth A.
    Jardin, Fabrice
    Piccaluga, Pier Paolo
    Weinstock, David M.
    Hammerman, Peter S.
    Yang, Henry
    Konopleva, Marina
    Pemmaraju, Naveen
    Garnache-Ottou, Francine
    Abdel-Wahab, Omar
    Koeffler, H. Phillip
    Lane, Andrew A.
    BLOOD, 2020, 136
  • [33] PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon
    Watarai, Hiroshi
    Sekine, Etsuko
    Inoue, Sayo
    Nakagawa, Ryusuke
    Kaisho, Tsuneyasu
    Taniguchi, Masaru
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) : 2993 - 2998
  • [34] Novel IKZF1 rearrangement identified in a patient with blastic plasmacytoid dendritic cell neoplasm decreased haematopoietic stem cell function and promoted plasmacytoid dendritic cell abnormality
    Yin, Le
    Yu, Qian
    Zhang, Huifang
    Zhu, Hongkai
    Deng, Zeyu
    Xing, Cheng
    Wang, Peilong
    Zeng, Xiangju
    Cheng, Zhao
    Sheng, Yue
    Peng, Hongling
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (06) : 2496 - 2500
  • [35] Venetoclax monotherapy as front-line therapy for blastic plasmacytoid dendritic cell neoplasm
    Shah, Ankit Mitesh
    Pereira, Denise
    Poveda, Julio
    Wang, Trent Peng
    LEUKEMIA RESEARCH REPORTS, 2023, 20
  • [36] Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents
    Shunan Wang
    Xingtong Wang
    Mingsuo Liu
    Ou Bai
    Annals of Hematology, 2018, 97 : 563 - 572
  • [37] Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm
    Ulrickson, Matthew L.
    Puri, Akshjot
    Lindstrom, Sarah
    Cassaday, Ryan D.
    De Padova, Nicolas
    Becker, Pamela S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (05) : E75 - E77
  • [38] Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents
    Wang, Shunan
    Wang, Xingtong
    Liu, Mingsuo
    Bai, Ou
    ANNALS OF HEMATOLOGY, 2018, 97 (04) : 563 - 572
  • [39] Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation
    Schmidt, B
    Scott, I
    Whitmore, RG
    Foster, H
    Fujimura, S
    Schmitz, J
    Levy, JA
    VIROLOGY, 2004, 329 (02) : 280 - 288
  • [40] Plasmacytoid Dendritic Cells as Cell-Based Therapeutics: A Novel Immunotherapy to Treat Human Immunodeficiency Virus Infection?
    van der Sluis, Renee M.
    Egedal, Johanne H.
    Jakobsen, Martin R.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10